CHOSA Signs US Laboratory Partner Agreement for Platin-DRP
CHOSA Oncology says it has signed an agreement with CLIA, which will serve as its certified laboratory partner for Platin-DRP in the US. First revenue is expected in summer 2027.
CHOSA Oncology says it has signed an agreement with CLIA, which will serve as its certified laboratory partner for Platin-DRP in the US. First revenue is expected in summer 2027.